A Phase 3 Trial of Brepocitinib in Dermatomyositis. Lundberg IE. N Engl J Med 2026;394:1953-1955.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lundberg IE. A Phase 3 Trial of Brepocitinib in Dermatomyositis. N Engl J Med 2026;394:1953-1955.
PMID: 42127396